In this week’s roundup: A look at the medtech implications from the Georgia Senate run-offs, marking the full coming of Brexit, regulatory news from China and India, and more to watch at FDA, CMS, and on Capitol Hill.
Democrats take Senate control. Brexit becomes reality. COVID-19 carries on, as global agencies try to branch out to more non-emergency policymaking. Welcome to 2021. Here’s what you need to know in the medtech realm in this first full week of the new year.